Correlation Between Memphis Pharmaceuticals and Arabia Investments

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Memphis Pharmaceuticals and Arabia Investments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Memphis Pharmaceuticals and Arabia Investments into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Memphis Pharmaceuticals and Arabia Investments Holding, you can compare the effects of market volatilities on Memphis Pharmaceuticals and Arabia Investments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Memphis Pharmaceuticals with a short position of Arabia Investments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Memphis Pharmaceuticals and Arabia Investments.

Diversification Opportunities for Memphis Pharmaceuticals and Arabia Investments

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between Memphis and Arabia is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Memphis Pharmaceuticals and Arabia Investments Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arabia Investments and Memphis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Memphis Pharmaceuticals are associated (or correlated) with Arabia Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arabia Investments has no effect on the direction of Memphis Pharmaceuticals i.e., Memphis Pharmaceuticals and Arabia Investments go up and down completely randomly.

Pair Corralation between Memphis Pharmaceuticals and Arabia Investments

Assuming the 90 days trading horizon Memphis Pharmaceuticals is expected to generate 1.69 times more return on investment than Arabia Investments. However, Memphis Pharmaceuticals is 1.69 times more volatile than Arabia Investments Holding. It trades about 0.08 of its potential returns per unit of risk. Arabia Investments Holding is currently generating about 0.05 per unit of risk. If you would invest  1,900  in Memphis Pharmaceuticals on October 13, 2024 and sell it today you would earn a total of  3,235  from holding Memphis Pharmaceuticals or generate 170.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy79.22%
ValuesDaily Returns

Memphis Pharmaceuticals  vs.  Arabia Investments Holding

 Performance 
       Timeline  
Memphis Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Memphis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Arabia Investments 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Arabia Investments Holding are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Arabia Investments may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Memphis Pharmaceuticals and Arabia Investments Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Memphis Pharmaceuticals and Arabia Investments

The main advantage of trading using opposite Memphis Pharmaceuticals and Arabia Investments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Memphis Pharmaceuticals position performs unexpectedly, Arabia Investments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arabia Investments will offset losses from the drop in Arabia Investments' long position.
The idea behind Memphis Pharmaceuticals and Arabia Investments Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.